Royalty Pharma Announces Inaugural Investor Day

NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will host an inaugural Investor Day in New York City on Tuesday, May 17, 2022, starting at 8:30 a.m. ET. Royalty Pharma senior executives will present on the outlook for royalty funding in life sciences, the company’s capital deployment opportunities and long-term growth targets. The meeting will include live question and answer sessions. Additional details will follow closer to the event. The l

Royalty Pharma Announces Inaugural Investor Day Read More »

3 Red Flags for Biogen’s Future

If you’re a former Biogen (NASDAQ: BIIB) investor like me, you might feel compelled to warn other people away from the stock. Since the U.S. Food and Drug Administration (FDA) approved its controversial Alzheimer’s drug Aduhelm in mid-2021, very little has gone right for the pharma company. When Aduhelm was approved on June 7, Biogen’s stock shot up wildly, as the market expected that the FDA would decline to let it proceed.

3 Red Flags for Biogen’s Future Read More »

SECURE Energy Announces Timing of Fourth Quarter and Year-End Results and Conference Call

SECURE Energy Services Inc. (“SECURE”, the “Corporation”) (TSX: SES) announced today that it expects to release its 2021 fourth quarter and year-end financial and operating results after market close on Wednesday, March 2, 2022. Financial Statements and Management’s Discussion and Analysis will be posted to SECURE’s website and SEDAR following the release.

SECURE Energy Announces Timing of Fourth Quarter and Year-End Results and Conference Call Read More »

Shopping Cart